日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A single cell transcriptional profile of benign prostatic hyperplasia.

良性前列腺增生的单细胞转录谱。

Unno Rei, Akutagawa Jon, Song Hanbing, Hui Keliana, Chen Yih-An, Pham Julia H, Lee Jean, Yang Heiko, Huang Franklin W, Chi Thomas

A single-cell and spatial atlas of prostate cancer reveals the combinatorial nature of gene modules underlying lineage plasticity and metastasis

前列腺癌的单细胞和空间图谱揭示了谱系可塑性和转移背后的基因模块的组合特性

Song, Hanbing; Xu, Junxiang; Velazquez-Arcelay, Keila; Demirci, Arda; Raizenne, Brendan L; Hsu, Sarah C; Choi, Joshua; Pham, Julia H; Chen, Yih-An; Weinstein, Hannah N W; Salzman, Isaac; Tsui, Margaret; Akutagawa, Jon; Adingo, Wisdom; Goldschmidt, Ezequiel; Carroll, Peter R; Hong, Julian C; Heaphy, Christopher M; Cooperberg, Matthew R; Greenland, Nancy; Campbell, Joshua D; Huang, Franklin W

A novel splice site variant in DEGS1 leads to aberrant splicing and loss of DEGS1 enzyme activity, a VUS resolved.

DEGS1 中的一种新型剪接位点变异导致异常剪接和 DEGS1 酶活性丧失,这是一个已解决的 VUS

Beale Holly C, Tse Victor, Lee Joanna Y, Akutagawa Jon, Mavura Yusuph, Saint-John Brandon, Cheney Allison, Mulligan Dennis R, Chacaltana Guillermo, Gutierrez Martin, Tenney Jessica, Shieh Joseph T, Martin Pierre-Marie, Yip Tiffany, Hodoglugil Ugur, Fay Alex J, Brooks Angela N, Van Ziffle Jessica, Stone Michael D, Risch Neil, Sanford Jeremy R, Devine Patrick, Saba Julie D, Vaske Olena M, Slavotinek Anne

The EBF1-PDGFRB T681I mutation is highly resistant to imatinib and dasatinib in vitro and detectable in clinical samples prior to treatment

EBF1-PDGFRB T681I 突变在体外对伊马替尼和达沙替尼具有高度耐药性,并且在治疗前可在临床样本中检测到。

Tran, Thai Hoa; Nguyen, Jonathan V; Stecula, Adrian; Akutagawa, Jon; Moorman, Anthony V; Braun, Benjamin S; Sali, Andrej; Mullighan, Charles G; Shah, Neil P; Dai, Yunfeng; Devidas, Meenakshi; Roberts, Kathryn G; Smith, Catherine C; Loh, Mignon L

Sustained MEK inhibition abrogates myeloproliferative disease in Nf1 mutant mice

持续抑制MEK可消除Nf1突变小鼠的骨髓增生性疾病。

Chang, Tiffany; Krisman, Kimberly; Theobald, Emily Harding; Xu, Jin; Akutagawa, Jon; Lauchle, Jennifer O; Kogan, Scott; Braun, Benjamin S; Shannon, Kevin

Sustained MEK inhibition abrogates myeloproliferative disease in Nf1 mutant mice

持续抑制MEK可消除Nf1突变小鼠的骨髓增生性疾病。

Chang, Tiffany; Krisman, Kimberly; Theobald, Emily Harding; Xu, Jin; Akutagawa, Jon; Lauchle, Jennifer O; Kogan, Scott; Braun, Benjamin S; Shannon, Kevin